Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective

Sree Harsha Tirumani, Jyothi P. Jagannathan, Katherine M. Krajewski, Atul B. Shinagare, Heather Jacene, Nikhil H. Ramaiya

Research output: Contribution to journalReview articlepeer-review

Abstract

OBJECTIVE. The purpose of this article is to review the decade-long experience with imatinib and other molecular targeted agents in the treatment of gastrointestinal stromal tumor (GIST). CONCLUSION. Tremendous progress has been made in the medical management of GIST since the inception of imatinib, and imaging has played a key role in understanding the typical and atypical responses of GIST to molecular targeted therapies.

Original languageEnglish (US)
Pages (from-to)801-810
Number of pages10
JournalAmerican Journal of Roentgenology
Volume201
Issue number4
DOIs
StatePublished - Oct 1 2013

Keywords

  • CT
  • Gastrointestinal stromal tumor
  • Imatinib
  • PET/CT

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Imatinib and beyond in gastrointestinal stromal tumors: A radiologist's perspective'. Together they form a unique fingerprint.

Cite this